Works matching IS 25094254 AND DT 2025 AND VI 9 AND IP 2
Results: 14
Economic Burden of Haemophilia from a Societal Perspective: A Scoping Review: Economic Burden of Haemophilia from a Societal Perspective: A. A. El-Sayed, N. S. Bolous.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 179, doi. 10.1007/s41669-024-00540-4
- By:
- Publication type:
- Article
Incorporating Resource Constraints in Health Economic Evaluations: Overview and Methodological Considerations: Incorporating Resource Constraints in Health Economic Evaluations: P. Thokala et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 161, doi. 10.1007/s41669-024-00537-z
- By:
- Publication type:
- Article
Correction: From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment: Correction: From Clinical to Non-clinical Outcomes in the Treatment of HIV: L. Ferrario et al.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Cost-Utility Analysis of LifeVest® in Post-Myocardial Infarction Patients at Risk of Sudden Cardiac Death in England: Cost-Utility Analysis of WCD in England: V. Kontogiannis et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 301, doi. 10.1007/s41669-024-00553-z
- By:
- Publication type:
- Article
What Does Pharmaceutical 3D Printing Cost? A Framework and Case Study with Hydrocortisone for Adrenal Insufficiency: What Does Pharmaceutical 3D Printing Cost: S. Ayyoubi et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 207, doi. 10.1007/s41669-024-00551-1
- By:
- Publication type:
- Article
Clinical Complications and Healthcare Resource Utilization Associated with Conventional Management of Sickle Cell Disease with Recurrent Vaso-occlusive Crises and Transfusion-Dependent β-Thalassemia in Germany: Complications and HCRU of SCD with Recurrent VOCs and TDT: C. Udeze et al
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 291, doi. 10.1007/s41669-024-00550-2
- By:
- Publication type:
- Article
Correction: Mapping the World Health Organization Disability Assessment Schedule (WHODAS 2.0) onto SF-6D Using Swedish General Population Data: Mapping WHODAS 2.0 onto SF-6D: A. Philipson et al.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Comparing Different Implementation Strategies for Collaborative Dementia Care Management in Terms of Patients' Characteristics, Unmet Needs, and the Impact on Quality of Life and Costs in Germany: Collaborative Dementia Care Management in Different Settings: M. Platen et al
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 271, doi. 10.1007/s41669-024-00548-w
- By:
- Publication type:
- Article
Health-Economic Modelling of Improved Behavior in Insulin Injection Technique in Belgium: Economic Impact of Reduced Insulin Pen Needle Reuse: K. Theys et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 259, doi. 10.1007/s41669-024-00547-x
- By:
- Publication type:
- Article
Cost-Effectiveness of Nivolumab Plus Ipilimumab versus Chemotherapy for Previously Untreated Metastatic NSCLC Using Mixture-Cure Survival Analysis Based on CheckMate 227 5-Year Data: Cost-Effectiveness of NIVO+IPI for NSCLC Using Mixture-Cure Survival Analysis: A. D. Griffiths et al
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 247, doi. 10.1007/s41669-024-00545-z
- By:
- Publication type:
- Article
The Association between COVID-19 Status and Economic Costs in the Early Stages of the COVID-19 Pandemic: Evidence from a UK Symptom Surveillance Digital Survey: COVID-19 and economic outcomes: S. W. Kim et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 231, doi. 10.1007/s41669-024-00544-0
- By:
- Publication type:
- Article
Burden of Disease of Breast Cancer in Italy: A Real-World Data Analysis: Burden of Disease of Breast Cancer in Italy: F. S. Mennini et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 283, doi. 10.1007/s41669-024-00543-1
- By:
- Publication type:
- Article
From Clinical to Non-clinical Outcomes in the Treatment of HIV: An Economic and Organizational Impact Assessment: Economic and Organizational Impact Assessment in the Treatment of HIV: L. Ferrario et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 313, doi. 10.1007/s41669-024-00542-2
- By:
- Publication type:
- Article
Economic Evaluation of Total Knee Replacement Compared with Non-Surgical Management for Knee Osteoarthritis in India: Economic Evaluation for Knee Osteoarthritis Management in India: A. S. Qadeer et al.
- Published in:
- PharmacoEconomics - Open, 2025, v. 9, n. 2, p. 217, doi. 10.1007/s41669-024-00541-3
- By:
- Publication type:
- Article